Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neurofibrosarcoma × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33 Leukemia 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Myeloid, Chronic-Phase 12 Gastrointestinal Stromal Tumors 12 Philadelphia Chromosome 5 Leukemia, Myeloid 5 Brain Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Blast Crisis 4 Recurrence 3 Prostatic Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Glioblastoma 3 Bone Marrow Diseases 3 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2 Leukemia, Myeloid, Accelerated Phase 2 Gliosarcoma 2 Glioma 2 Digestive System Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

Doxorubicin 4 pazopanib 3 Ifosfamide 3 Sorafenib 2 Sirolimus 2 Radiotherapy 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 tazemetostat 1 romidepsin 1 pexidartinib 1 lorvotuzumab mertansine 1 liposomal doxorubicin 1 indolepropanol phosphate 1 fludarabine phosphate 1 Watchful Waiting 1 Thiotepa 1 Tacrolimus 1 Sunitinib 1 Stem Cell Transplantation 1 STA 9090 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡